SightfileU.S. market data from official filings

Neonc Technologies HLDGS (NTHI)

Name: Neonc Technologies HLDGS (NTHI) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001979414 · EDGAR filings · Updated 2026-07-15

Neonc Technologies HLDGS (NTHI) has reported institutional ownership of 12.2%, with 27 institutional managers holding positions valued at $20.3M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

12.2%

Institutional managers

Reported 13F value

$20.3M

Insider activity

65 trans.

−$7.25M net selling

Data flags

2 active

from SEC filings

Latest updates

2026-07-15 — Current report (8-K) filed
2026-07-13 — Insider transaction reported (Form 4)
2026-07-13 — Initial insider ownership filed (Form 3)
2026-07-02 — Current report (8-K) filed
2026-06-25 — D filed
2026-06-23 — EFFECT filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Neonc Technologies HLDGS has 27 institutional holders and institutional ownership of 12.2%.

Insider activity

Insiders reported 65 transactions (21 buys, 20 sells) across 7 reporting insiders, with a net reported value of −$7.25M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2025-05-09) — source filing. The authoritative details are those stated in the filing itself.

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2025-08-20 (recurring since 2025-08-18) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Aligos Therapeutics Inc (ALGS) · BIOTE CORP (BTMD) · Seres Therapeutics Inc (MCRB) · Grace Therapeutics Inc (GRCE) · PELTHOS THERAPEUTICS INC (PTHS) · Instil Bio Inc (TIL)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.